Search for a reference number

Responses

Patient Information Leaflets

Subject: Freedom of Information Request – Patient Information Leaflet Management –

Dear Freedom of Information Officer, I am writing to make a request under the Freedom of Information Act 2000.

Please provide the following information about the management of patient information leaflets:

1. OPERATIONAL RESPONSIBILITY The job title(s) of the person(s) or team responsible for the development, production, approval, and management of patient information leaflets (including printed and digital materials).

2. DOCUMENT VOLUME AND PRODUCTION – The approximate number of patient information leaflets currently maintained by the Trust – The software or system(s) used to produce and manage these leaflets (e.g., Microsoft Word, desktop publishing software, dedicated patient information management systems)

3. REPORTING STRUCTURE The job title of the senior manager to whom the person(s)/team(s) in question 1 directly report.

4. BOARD-LEVEL ACCOUNTABILITY The job title of the Board-level executive with overall accountability for patient information materials.

5. GOVERNANCE FRAMEWORK If the Trust has a formal policy or governance document covering patient information leaflets, please provide: – The document title and version number – The job title of the Board-level signatory or accountable executive named in that document – OR a copy of the policy itself if more convenient Please note: I do not require personal data such as names or contact details – job titles and reporting structures are sufficient.

If any part of this request is likely to exceed the cost limit under Section 12 of the Act, please advise how the request could be refined. I would prefer to receive this information in electronic format. I look forward to your response within 20 working days as required by the Act.

Yours faithfully

EHRC consultation

HR, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust,

I hope you are well. Between 20 May and 30 June 2025, the Equality and Human Rights Commission (EHRC) ran a consultation on proposed changes to their Code of practice for services, public functions and associations (the consultation).

I would like to please request a copy of your trust’s response to this consultation. I am aware some bodies submitted responses to the consultation via the EHRC’s web form, while others submitted documents formatted themselves.

I would be grateful if you could provide me with what was submitted to the EHRC by the trust, in whatever format it is held – whether a document that was copied from into the EHRC’s form, a PDF file, a printout of the completed form, or however you hold the information.

If you have already published this information then I apologise and would be grateful please if you could direct me to where exactly it is available.

Yours faithfully,

Use of Electroconvulsive Therapy (ECT)

Health, MH Services

Dear Sir/Madam,
I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).
The information being requested is as follows:

1. Please provide the number of ECT treatments given to patients (if any) in the year 2025

2. Please provide the number of patients (if any) having received ECT treatment in the year 2025

I look forward to hearing from you in due course.

Yours faithfully,

Non-British patients

Clinical Activity Data, Finance

Dear FOI Team,

I am writing to obtain information about the number of non-British citizens treated by your trust. Please include the following for the previous 3 financial years (2022-23, 2023-24 and 2024-25) :

• The total number of non-British citizens treated in the previous 3 financial years.
• The total cost of treating those patients
• The total amount recovered from those patients
• The total number of adults treated who did not have a NHS number in the previous 3 financial years
• The total cost of treating those patients
• The total amount recovered from those patients

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
If you have any queries please do not hesitate to contact me.

Best wishes,

Workforce Planning for Prosthetic and Orthotic Services

Podiatry

Dear FOI Officer,

Please find attached a request for information under the Freedom of Information Act 2000 (or the Freedom of Information (Scotland) Act 2002 where applicable), submitted on behalf of the British Association of Prosthetics and Orthotics (BAPO).

The request relates to workforce planning arrangements for Prosthetic and Orthotic services within your organisation. The attached document contains 10 questions, most of which require brief factual responses. Definitions are included to support consistent interpretation.

1. Does your Trust/Health Board currently provide or commission a Prosthetic service? Yes/No

2. Does your Trust/Health Board currently provide or commission an Orthotic service for patients? Yes/No

3a. If you answered Yes to Question 1: Is your Prosthetic service delivered in-house (i.e. directly employed NHS staff) or is it contracted out to an external provider?

In-house / Contracted / Mixed (please specify) / Not applicable

3b. If you answered Yes to Question 2: Is your Orthotic service delivered in-house (i.e. directly employed NHS staff) or is it contracted out to an external provider?

In-house / Contracted / Mixed (please specify) / Not applicable

4. Does your Trust/Health Board carry out workforce planning analysis for your Allied Health Professional (AHP) workforce? Yes/No

5a. If you answered Yes to Question 4: Does your AHP workforce planning specifically include your Prosthetic service workforce (whether in-house or contracted)? Yes/No/Not Applicable

5b. If you answered Yes to Question 4: Does your AHP workforce planning specifically include your Orthotic service workforce (whether in-house or contracted)? Yes/No/Not Applicable

6a. If your Prosthetic service is contracted out (as indicated in Question 3a): Does your Trust/Health Board carry out workforce planning for the contracted Prosthetic service? Yes/No/Not Applicable

6b. If your Orthotic service is contracted out (as indicated in Question 3b): Does your Trust/Health Board carry out workforce planning for the contracted Orthotic service? Yes/No/Not Applicable

7a. If you answered Yes to Question 6a: How does your Trust/Health Board collate workforce planning data from the contracted Prosthetic service provider? Please describe the process, including the frequency of data collection and what data is gathered.

7b. If you answered Yes to Question 6b: How does your Trust/Health Board collate workforce planning data from the contracted Orthotic service provider? Please describe the process, including the frequency of data collection and what data is gathered.

8. If your Trust/Health Board does not carry out workforce planning for its Prosthetic and/or Orthotic services (whether in-house or contracted), please explain what steps you are taking to secure the prosthetic and/orthotic workforce pipeline.

9. Does your Trust/Health Board include data from its Prosthetic and/or Orthotic services (whether in-house or contracted) in any workforce returns submitted to NHS England, NHS Wales, NHS Scotland, or equivalent national workforce planning bodies? Yes/No/Dont Know please specify which returns

10. Please provide the current whole time equivalent (WTE) staffing establishment for your Prosthetic and/or Orthotic services, brokendown by: (a) Prosthetists, (b) Orthotists, (c) Prosthetic/Orthotic Technicians, (d) Prosthetic/Orthotic support workers (e) Please indicate whether each figure relates to in-house or contracted staff. (Numerical breakdown with in-house/contracted designation)

If you require any clarification to assist with a timely response, please contact me at the details below.

Yours faithfully,

Multi-Functional Devices (MDF) Fleet

IT, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust,

Please can you provide the following information, under this freedom of information request?

1). Number of printers and multi-functional devices you have?

2). Suppliers of devices in question 1?

3). Contract dates for devices in question 1?

4). Planned procurement activity around replacement of your printers and multi-functional devices including any preferred framework route?

5).please also confirm any print management software currently in use?

6). Please can you confirm the contact details for the person responsible for overseeing you print solution?

Dravet Syndrome and Lennox-Gastaut Syndrome

Clinical Activity Data

Dear FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Where possible, I would be grateful if the requested data could be provided in an editable format (e.g. .xlsx or .csv). If this is not feasible, a table format would also be acceptable, and example layouts are suggested below for reference.

For all questions, patient numbers should represent unique patients within the specified reporting period. Where a monthly breakdown is not available, please provide unique patient numbers aggregated by quarter instead. If the tables below are not showing correctly due to formatting issues, then please let me know and I can send them in a word document.

Priority questions:

1. The number of patients under the trust’s care with a recorded diagnosis of Dravet syndrome in each month of 2025 (January–December). Patients may be counted in more than one month. Likely coded as ICD-10 code G40.3 or SNOMED code 230437002.
a. Patient numbers segmented by age:
i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ 2. The number of patients under the trust’s care with a recorded diagnosis of Lennox-Gastaut syndrome in each month of 2025 (January-December). Patients may be counted in more than one month. Likely coded as ICD-10 code G40.4 or SNOMED code of 230418006. a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ Example table for Q1 & 2: Age/Month Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 <2 years old 2-8 years old 9-17 years old 18+ years old 3. The number of patients under the trust’s care who have been treated with fenfluramine in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 Example table for 3 – 12 a)i – b)ii Age group / Month Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 <2 years Total patients Dravet syndrome Lennox–Gastaut syndrome 2-8 years Total patients Dravet syndrome Lennox–Gastaut syndrome 9-17 years Total patients Dravet syndrome Lennox–Gastaut syndrome 18+ years Total patients Dravet syndrome Lennox–Gastaut syndrome c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 4. The number of patients under the trust’s care who have been treated with cannabidiol in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 5. The number of patients under the trust’s care who have been treated with cenobamate in in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 6. The number of patients under the trust’s care who have been treated with rufinamide in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 7. The number of patients under the trust’s care who have been treated with stiripentol in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. Good to know questions: 8. The number of patients under the trust’s care who have been treated with clobazam in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 9. The number of patients under the trust’s care who have been treated with sodium valproate in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 10. The number of patients under the trust’s care who have been treated with topiramate in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 11. The number of patients under the trust’s care who have been treated with lamotrigine in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. Many thanks,

Clinical Activity Data / Finance – Asylum Seekers

Clinical Activity Data, MP

Dear FOl Officer,

Under the Freedom of lnfom1ation Act 2000, I request the following information for the financial years 2022/23, 2023/24 and 2024/25:

1. The total number of patient episodes (e.g., emergency, inpatient, outpatient) recorded in your trust’s systems where the patient was flagged as an asylum seeker or exempt from charging due to asylwn/refugee status.

2. Total NHS expenditure associated with those episodes, by category where available (e.g., by service type such as A&E, inpatient, outpatient, prescriptions, maternity).

3. Whether your trust records immigration status or charging exemption codes that can distinguish asylum seekers from other charging exemption categories.

Please provide this information in a machine-readable format (e.g., CSV or Excel) where possible.

If you believe supplying the financial cost data would exceed the appropriate cost limit, please provide the patient episode counts and, separately, any average cost figures you can supply.

I confirm that I am requesting this information under the Freedom of Information Act, and I look forward to your response within 20 working days.

Yours sincerely,

Nurses on Long-Term Sick Leave

Nursing & Agency Nursing, Staffing

Dear FOI officer,

I am writing to request information under the Freedom of Information Act 2000 regarding the number of registered nurses on long-term sick leave.

Please provide the following information, using the most recent data available, as well as the same information for the equivalent, or nearest, date in 2021 and 2016.

1. ‎ The total number (head count) of all registered nurses employed by the trust or health board at Agenda for Change Band 5 and above. [E.g. 02/02/2026 – 1,506; 02/02/2021 – 1,321; 02/02/2016 – 1,234]

2. Of these registered nurses (Band 5 and above), how many are/were absent from work on long-term sick leave, which is defined as sickness absence lasting more than 28 consecutive calendar days. [E.g. 02/02/2026 – 30; 02/02/2021 – 12; 02/02/2016 – 25]
If possible, please confirm the date at which each dataset was accurate.

Please return this information within the 20-working day deadline provided under statute – by my reckoning this is Friday 13 March.

Please let me know if you have any questions in order to process this request.

Hospital Data (ICD-10)

Clinical Activity Data

Dear Sir or Madam,

I am writing to make a request under the Freedom of Information act

I am seeking hospital-level activity data within your health authority, as outlined below.

Dataset 1: ICD-10 Diagnosis Data

For each hospital, please provide:
• From 2022 up to the latest data available, preferably by calendar year
• Primary (first) diagnosis ICD-10 codes (three or more characters), chapters A–Q only, including patients outsourced to the private sector
• Number of cases per ICD-10 code
• Hospital name and postcode

Dataset 2: Procedures / Surgery Data

For each hospital, please provide:
• Years: 2020 up to and including 2024, preferably by calendar year
• Primary procedure OPCS codes, all chapters, including patients outsourced to the private sector
• Number of cases per OPCS code
• Hospital name and postcode

With regard to case numbers for both ICD-10 and OPCS data, we recognise that disclosure controls may apply where case numbers are fewer than five. In such instances, please indicate the value as “<5” or similar format, depending on your small-case policy. We would be grateful if the data could be provided in a machine-readable format (for example, CSV or Excel), if possible. For context, we already hold comparable datasets for most European countries. This information is collected and processed for research and pharmaceutical organisations, where it is used for market analysis and clinical trial planning. We hope this explains the purpose and potential value of supplying the requested data. Please let us know if any clarification is required. I look forward to hearing from you.

Band 7/8 Registered Nurse Workforce

Nursing & Agency Nursing

Dear FOI officer,

Under the terms of the Freedom of Information Act, 2000, please supply me with the following information about your registered nurse workforce, (if possible, laid out as below):

1) Please state how many full-time (FT) equivalent registered nurses your trust employs at the following banding levels:

Band Number in 2026 Number in 2025 Number in 2024 Number in 2023 Number in 2022
7
8

2) (i) If known, please state how many FT equivalent clinical nurse specialists your trust employs both now and in 2022, please show by AfC band if possible:

Number of clinical nurse specialists employed at present time (at band?) Number of clinical nurse specialists employed in 2022 (at band?)

(ii) Areas of clinical practice covered (if it is possible to provide this info): ¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬-__________________________________________________________________________________

3) Finally, please state how many FT equivalent nurses your trust currently employs:

Total number of FT nurses employed by your trust at any banding level

Applicant Tracking System (ATS)

Contracts

Dear Freedom of Information Team,

I am writing to make a request under the Freedom of Information Act 2000.
Please provide the following information relating to the Applicant Tracking System (ATS) currently used by Gloucestershire Health and Care NHS Foundation Trust:
ATS details
• The name of the Applicant Tracking System currently in use:
• The supplier/vendor of the system:
Contract information
• The start date of the current ATS contract:
• The end date of the current ATS contract:
• Any extension options included within the contract (if applicable):
• Contract value (£):
Future procurement
• Whether the Trust intends to re tender for the ATS at the end of the current contract:
• If known, the anticipated timeframe for any future tender or procurement process:
Contract ownership
• The job title and department of the officer with primary responsibility for managing the current ATS contract:
Procurement responsibility
• The job title and department of the person primarily responsible for procurement of recruitment or HR systems within the Trust:

If any part of this request is exempt from disclosure, please identify the relevant exemption(s) and provide any information that can be disclosed.
I am happy to receive the response by email. If clarification is required to process this request, please let me know as soon as possible.

I understand that under the Freedom of Information Act, you are required to respond within 20 working days.

Kind regards,

Impact of NHS Financial Requirements

Finance

Freedom of Information Act Request: Impact of NHS financial requirements
SECTION ONE: financial breakeven requirements
From 2025-26, NHS England’s financial framework requires NHS trusts to meet a statutory breakeven duty. Where possible, trusts must avoid in-year deficits and recover prior deficits.
Request (section one):
1. Please provide the trust’s in-year deficit or surplus for 2024–25, and its estimated in-year deficit or surplus for 2025–26, 2026–27 and 2027–28. (Where the trust plans to break even, please confirm this. Where a deficit or surplus is projected, please state the estimated value.)
SECTION TWO: efficiency, productivity and cost-reduction requirements
NHS England has set mandatory efficiency measures, including: reducing organisational cost base by at least 1%; delivering around 4% productivity improvement; reducing corporate service spending to pre-pandemic levels; and reducing reliance on temporary and agency staffing.
Request (section two):
2a. Workforce reductions and permanently deleted posts
Please provide the total number of job cuts, redundancies or post reductions that the trust has identified, planned or already implemented as a result of its breakeven duty and associated financial planning. If possible, please provide this information by financial year: 2025–26, 2026–27 and 2027–28.
This should include job cuts or redundancies, and posts that have already been permanently deleted whether or not this resulted in redundancy.
Where possible, and within statutory cost limits, please break this information down by staff group, for example: clinical staff, non-clinical staff, corporate / administrative staff
Please express figures in full-time equivalent (FTE). Where only headcount figures are held, please provide these instead and indicate this.
2b. Method of workforce reduction and post deletion
Where possible, please provide a breakdown of how the workforce reductions and permanent post deletions described in section 2a are being or will be achieved, for example through: compulsory redundancies, voluntary redundancies, non-renewal of fixed-term contracts, natural wastage, vacancy controls or recruitment freezes.
Where data is held, please break this information down by staff group (clinical/non-clinical/corporate, or equivalent categories used by the trust) and by financial year (2025–26, 2026–27, 2027–28).
SECTION THREE: planned service reductions
Breakeven planning may involve changes to service delivery, including reductions, reconfiguration or cessation of services.
Request (section three):
3. Please outline any services, departments or functions that the trust has identified for reduction, reconfiguration or closure as part of its breakeven duty and medium-term financial plan, and indicate in which financial year(s) these changes are planned (2025–26, 2026–27 and/or 2027–28).
I would be grateful if you could treat this request under the Freedom of Information Act 2000. If any part of the request is unclear or likely to exceed the statutory cost limit, please advise how it may be refined. I look forward to your response within 20 working days.
Kindest regards,

Nursing Service

Nursing & Agency Nursing

I am looking for this information due to establishing a better understanding of the needs of any nursing services you provide, along with the service users covered. No documentation is required, however full and clear disclosure is appreciated. Unless otherwise stated, all questions relate to Nursing usage only.

1. Please provide name and contact details (email address and telephone number where possible) of the following (broken down per site):

a) Temporary Staffing Manager or Staff Bank Manager
b) Lead Cancer Nurse and/or;
c) Cancer Manager

2. How much nursing agency usage from January 2025 to December 2025 has the Trust used? This is a request for Nursing only. I request for this information to be broken down into the following:

a) unit/site and ward/department
b) grade/title (i.e. Band 5/6/7 Nurse etc.)
c) amount of hours and/or full time equivalent (FTE) broken down per month during the requested time period above
d) total cost of agency usage (in £) per month during the requested time period above
e) what agencies were used, along with total amount in £ per agency on a monthly basis during the requested time period above
f) of these agencies, who were classified as ‘off framework’ and ‘on framework’ 3. How does the Trust source any Nurse agency requirements? I request your answer include any frameworks that you use along with the number of SLAs you have in place with providers.

4. Based on your answer above, can you confirm the number of incidences whereby your agency need has been charged above NHSi cap, broken down per shift on a monthly basis i.e. April 2018 = 25 shifts and by what agency

5. Who is responsible for making the decision on which agency/recruitment business to use to fulfil your agency nursing requirements. Please include name and contact details (email and telephone number where possible).

6. What are the Trusts current full-time and part-time vacancies for:

a) Cancer Clinical Nurse Specialists
b) Lead Cancer Nurse
c) Cancer Manager
d) Chemotherapy Nurses
e) Radiology Nurses
f) Oncology Nurses
g) General Nurses (all specialisms)

Spiking Cases from October 2021 – September 2025

Safety and Security, Serious Incidents

Good Afternoon,

My name is Emily Youngs, and I am studying BSc (Hons) Crime and Investigative Studies. As part of my studies. I am currently conducting a study on spiking under the supervision of Dr. Lata Gautam, Principal Investigator for Spiking Research at Anglia Ruskin University. This research has received full ethical approval from the Faculty Research Ethics Panel [ETH2526-0983].
Under the Freedom of Information Act 2000, I would like to request the following information your organisation may hold regarding incidents of spiking:
1. The number of recorded incidents of suspected spiking cases from October 2021 – September 2025, broken down by month where possible.
2. Where available, provide a breakdown of the information, such as grouped data or percentages:
a. Type of spiking methods – needling, drink spiking, food spiking, vape spiking and any other means
b. Gender – Male, Female, Non-binary, Not disclosed, Other
c. Age group of individuals at the time of alleged spiking –
• Below 18
• 18 to 24
• 25 to 34
• 35 to 44
• 45 and above
d. Setting/location type where spiking took place (bar, nightclub, private residence, university accommodation, others)
3. Copies of or link to any guidance, protocols, or policies your organisation has for responding to suspected spiking incidents.
4. This question is for Sexual Assault Referral Centres — do you accept reports of spiking even if there hasn’t been a sexual assault?

Thank you for your assistance.

Yours sincerely,

Maternity Service – Obstetric Cholestasis Policy

GHNHSFT - Redirect

I would like to have a copy the policy document on Obstetric cholestasis (intrahepatic Cholestasis of pregnancy)

Catering Procurement

Estates

Dear Sir or Madam,

I am writing to request information under the Freedom of Information Act 2000.

Please provide the following information in relation to your organisation’s catering procurement:

1. The total amount spent on bacon and ham products (including, but not limited to, fresh, frozen, processed, or pre-packaged bacon and ham) for each of the last 5 full financial years.

2. Where available, a breakdown of this expenditure by financial year.

For the avoidance of doubt, this request relates only to expenditure on bacon and ham products and does not require information on other meat products.

If the information is held electronically, I would prefer it to be provided in a machine-readable format such as Excel or CSV.

If fulfilling this request in full would exceed the cost limit, I would be grateful if you could provide advice and assistance under section 16 of the Act as to how the request could be refined.

I look forward to your response within the statutory 20 working days.

Pharmacy – Immunoglobulin Vials/Volume in Grams

GHNHSFT - Redirect, Pharmacy

To Whom It May Concern,
I would like to submit an FOI request for the following data for Gloucestershire Health and Care NHS Foundation Trust:

The number of immunoglobulin vials/volume in grams distributed to Gloucestershire Health and Care NHS Foundation Trust in each month for October, November, and December 2025, broken down by product (see below). I would also like to request the number of patients by brand if available

* Vigam

* Flebogamma DIF

* Gammaplex

* Gamunex-C

* Octagam

* Gamten

* Kiovig

* Intratect

* Privigen

* Iqymune

* Gammanorm

* Subcuvia

* Subgam

* Hizentra

* Hyqvia

* Cuvitru

* Panzyga

* Xembify

* Cutaquig

• Vyvgart (Efgartigimod)

Preferably I would like the data in .xlsx or .csv format. Alternatively a table will suffice

Thanks for your support.
Best,

Staffing Information

ESR/Workforce, Staffing

Dear Sir/Madam,

Under the Freedom of Information Act, I would be grateful if you could confirm the following:

1. The name of the department within the organisation that is responsible for providing Information to the organisation, e.g. Information Team, Business Intelligence etc.
2. Confirmation as to whether the above team also has responsibility for monitoring and reporting corporate performance or whether this is undertaken by a separate team?
3. The budgeted WTE of the department in Question 1.
4. The budgeted WTE of the corporate performance department in Question 2 (if it sits separately to the team in Question 1).
5. The total budgeted WTE for the Trust.
6. Please provide a structure chart for the department in Question 1, showing post titles and banding.

I would be grateful if you could provide the information above in email format to this email address.

Please contact me if you need me to clarify my request, again via this email address.

Use of Topaz Signature Pads with TPP SystmOne

Dear FOI Team,

I am submitting the following request under the Freedom of Information Act 2000.

1. Does the Trust use TTP SystmOne as Electronic Patient Record?
(if no, no further questions required)

2. Does the Trust use signature pads (e.g.Topaz or any other signature pad provider) in any service areas?

3. If yes, please list the make, models in use and the departments or services where they are deployed.
4. Are these devices integrated with TPP SystmOne for capturing patient or staff signatures?
5. If integrated, please briefly describe the type of workflow (e.g., consent forms, care plans, community documentation).

No personal or clinical data is requested.
Please respond to this email address as I work remotely.
Thank you for your assistance.

Night-time In-Patient Care Implemented 24/25

Health, Staffing

Dear Gloucestershire Health and Care NHS Foundation Trust,

This request seeks information on practical service improvements in night-time inpatient care implemented during 2024/25, to support shared learning and benchmarking across NHS Trusts. The focus is on sleep, noise, and night-time disruption aligned with issues highlighted in the Care Quality Commission Adult Inpatient Survey.

Please answer for adult inpatient services

Night-time care and sleep
1. Night-time improvement initiatives
Please describe any Trust-wide or ward-level initiatives in place during 2024/2025 aimed at improving patients’ experience at night (e.g. reducing noise, improving sleep, reducing night-time disruption).

2. Policies or protocols
Does the Trust have any formal policy, protocol or guidance relating to:
o noise reduction at night,
o minimising non-urgent interventions overnight,
o minimising non-urgent ward moves during night hours?
If yes, please provide the title(s) and date(s).

3. Ward moves at night
During 2024/25, did the Trust take any specific actions to reduce non-urgent patient transfers or bed moves overnight (for example after 11pm)?
If yes, please describe the actions taken.

4. Staff training and awareness
Has the Trust delivered any training, briefings or awareness campaigns during 2024/25 relating to night-time care, sleep, noise reduction?
If yes, please describe.

5. Measuring impact
Please indicate which of the following are used to assess night-time care experience:
o National Inpatient Survey sleep/noise questions
o real-time patient feedback
o complaints or PALS themes
o local audits or ward observations
(Please specify all that apply.)

Yours faithfully,

Talking Therapy Provider

Contracts, Health, MH Services

Dear Gloucestershire Health and Care NHS Foundation Trust,

I would be most grateful if you would provide me, under the Freedom of Information Act, answers to the below questions:
1.
For contracts held with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, please confirm:
• The contract start and end dates
• Whether the contract is block-funded, activity-based, or outcome-based
• Whether payment is triggered by completed contacts, completed episodes of care, or other milestones

2.
For each financial year from 2022/23 to 2024/25, please confirm the total expenditure paid to each of the external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services.

3.
For the same period, please provide:
• The total number of completed clinical contacts delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services and/or
• The total number of completed treatment episodes (courses of care), broken down where available by Step 2 and Step 3

4.
If held, please provide any internally reported or calculated figures showing:
• Average cost per completed treatment episode
• Average cost per completed clinical contact
for services delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services

5.
Please provide any board papers, performance reports, or internal evaluations which reference:
• Recovery rates, reliable improvement, or waiting-time performance
• In relation to the cost or value for money of services delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services

6.
Please confirm whether external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, costs were benchmarked against:
• In-house NHS Talking Therapies provision
• Other external providers
and if so, whether the supplier was assessed as lower-cost, comparable, or higher-cost.

7.
Please confirm whether the contract with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, included:
• Minimum activity volumes
• Volume caps
• Break clauses linked to activity or outcomes

8.
Please list any contract variations, extensions, or price uplifts agreed with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, since contract award, including the reason (e.g. demand growth, workforce pressures).

9.
Please confirm whether charges payable to external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, included separate line items for:
• Referral processing
• Digital platform access
• Administration or reporting
and if so, the value of these charges.

10.
Please confirm whether the ICB/Trust anticipates:
• Re-tendering
• Extending
• Expanding
NHS Talking Therapies capacity using external providers within the next 24 months.

Yours faithfully,

Robotic-Assisted Surgery

GHNHSFT - Redirect

Dear FOI team,
I am writing to request the following information under the Freedom of Information Act 2000.
Please provide the following recorded information relating to robotic-assisted surgical platforms currently available within your trust.
1. For each robotic-assisted surgical platform currently available within your trust, please provide:
• Manufacturer
• Model
• Date acquired or first brought into service
• Whether the platform is owned, leased, rented, or accessed via another arrangement
2. For each platform listed above, please specify the surgical specialties that use it.
3. For each platform, please provide the recorded source(s) of funding used to acquire or access it (e.g., trust capital, charitable funding, lease payments, donations, managed service agreements, third party funding arrangements).
4. Where charitable or philanthropic funding contributed to the acquisition or access arrangements for any platform, please provide:
• Name of the charitable organisation(s)
• Amount contributed by each
• Date the funding was received or allocated
5. Please provide the recorded annual cost of:
• Maintenance or servicing
• Consumables (if recorded separately)
• The funding source(s) used to meet these costs (e.g., trust budgets, charitable sources, managed service contract, warranty)
6. For each platform, please confirm whether it was acquired via an NHS Supply Chain framework or another procurement route, as recorded.

Open Vacancies FOIs

Staffing

Dear all, I am writing to request under the Freedom of Information Act 2000.

Q1. please can you let me know how many WTE within your trust in your team deal with FOI requests? for example – 1 WTE Band 4/5 Freedom of Information Officer.

Q2. What is their Band?

Q3. Do they work remotely from home or Hybrid role?

Q4. Any open vacancies/post within your Governance Team?

I look forward to hear from you within the 20 day statuary working days.

Warm Regards

Guidelines for the Treatment of Patients with Schizophrenia.

Health, Pharmacy

Dear Sir/Madam,
Please find below an FOI request relating to the treatment of patients with schizophrenia.
Question 1: Does Gloucestershire Health and Care NHS Foundation Trust have any local guidelines for the use of antipsychotic medications for the treatment of schizophrenia? Yes/No
If yes, please provide a copy.

Question 2: Does Gloucestershire Health and Care NHS Foundation Trust have any policies for the use of antipsychotic medications in the form of Long acting injectables (LAIs)/Depot injections for any mental health condition? Yes/No
If yes, please provide a copy.

Thank you in advance for your assistance,

Patients Awaiting Initial Assessment-Memory Clinics-Suspected Dementia

Clinical Activity Data, Health, MH Services

Dear Sir/Madam, Under the Freedom of Information Act 2000, I would like to request the following information relating to waiting lists and waiting times for patients awaiting an initial assessment at memory clinics for suspected dementia:

1. Waiting List Size

o The number of patients currently on the waiting list for an initial memory clinic assessment for suspected dementia, as of the most recent available date.

2. Waiting Times

o The average waiting time (in weeks and/or days) from referral to first assessment at your memory clinic for suspected dementia for the most recent reporting period.
o The median waiting time (if available).
o The range of waiting times (shortest and longest) for patients currently on the waiting list.

3. Historical Data

o The waiting list size and average waiting time for the same service for each quarter over the last 12 months (e.g., Q1, Q2, Q3, Q4).

4. Referral and Assessment Source Data

o The number of referrals received in the last 12 months for memory clinic assessments for suspected dementia.
o The number of patients assessed and discharged from the waiting list in the last 12 months.

Please provide this information in an electronic format (e.g., Excel or CSV) if possible.

If you consider any part of this request to be exempt, please provide reasons for your decision, including the relevant exemption clauses.

If the full information is not available, please provide what you do hold and advise how much of the requested information you are unable to supply.

I look forward to your response within 20 working days, as required under the Act.

Yours faithfully,

ASD and ADHD services for children, young people, and adult

Clinical Activity Data, Health

Good Morning,

We have recently been awarded NHS Standard Contracts to deliver ASD and ADHD services for children, young people, and adults, including diagnostic assessments and ongoing treatment where appropriate, such as medication and psychoeducation.

As a result, we’re now beginning to receive Right to Choose referrals from patients registered with GP practices in your area.

We are trying to gather as much information as possible to be proactive within our service.

We are formally asking your assistance by providing us with answers to our questions below.

1 Child ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

2 Child ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

3 Adult ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

4 Adult ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

Thanking you in advance for your assistance

with Kind regards

Locum Doctors

ESR/Workforce

Good Morning,

Please can I request the below information:

In the period 1st November 2025 to 31st January 2026 please provide a breakdown of:
• Total trust spend with framework agencies for locum doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per agency name
 
In the period 1st November 2025 to 31st January 2026 please provide a breakdown of:
• Total trust spend with off-framework agencies for locums doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per agency name
 
In the period 1st November 2025 to 31st January 2026 please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per internal or associated external provider

Please confirm your allocated budget for agency locum doctors for the period 1st November 2025 to 31st January 2026

Please confirm the name of the framework used for the supply of locum doctors in your trust.

Thanks in advance

Telephone System

Dear, Gloucestershire Health and Care NHS Trust
Under the Freedom of Information Act, I would like to request the following information.
Telephone System
What make is your telephone system?
How old is the telephone system you operate?
How many users do you have?
Is your telephone system cloud based or on premise?

Can your switchboard operators transfer external incoming calls to all users across your estate?

How many extensions does your telephone system have?

Telecoms Estate

How much do you spend annually on telecoms?
Do you know how this is split into Voice Telecoms / Data Networking / Mobile Communications / Maintenance?
Which suppliers do you use for Voice / Data / Mobile / Maintenance?

How many analogue lines do you have?
How many ISDN2 Services do you have?
How many ISDN30 Services do you have?
How many mobiles do you have?
Have you done anything about the Analogue Switch Off / Digital Switch On? If so, what have you done?
What are the contact details for the person who looks after telecoms and the costs associated with these?
Microsoft
How much do you spend annually with Microsoft?
How often do you review licensing costs?

Many Thanks & Best Regards

Macerators / Bedpan Washers

Estates

Dear Freedom of Information Team,

I am writing to you under the Freedom of Information Act 2000 to request information relating to infection prevention practices within your Trust, specifically in relation to the use, servicing, and management of sluice room equipment (bedpan washers and/or macerators).

The purpose of this request is to gain a better understanding of current approaches across NHS Foundation Trusts so that we can explore how we may be able to support Trusts through value-based procurement and improved infection prevention outcomes.

Please could you provide the following information:

1. Who is the current supplier of your macerators and/or bedpan washers?

2. Who is responsible for servicing and maintaining these machines (e.g. the original equipment manufacturer, a third-party service provider, or in-house teams)?

3. When does the current contract for the supply and/or servicing of this equipment expire?

4. Which department or role within the Trust is responsible for managing these contracts?

If any of the requested information is held in multiple formats or contracts, please provide the information in the form most readily available.

If any part of this request is exempt under the Act, I would appreciate it if you could provide the non-exempt portions and advise on the applicable exemptions.

Thank you for your time and assistance.

I look forward to your response within the statutory timeframe.

Kind regards

Sonographers

Contracts, Staffing

To whom it may concern,

For the 6-month period ending 1st January 2026, can you please provide:

1. Total Framework Agency Spend for Sonographers.
2. Total Off Framework Agency Spend Sonographers.
3. Total hours filled by Framework Agencies for Sonographers and a breakdown of hours filled.
4. Total hours filled by Off Framework Agencies for Sonographers and a breakdown of hours filled.
5. A list of all Framework Agencies utilised by the Trust for Sonographers.
6. A list of all Off Framework Agencies utilised by the Trust for Sonographers and total number of shifts for each Off Framework agency.
7. The highest Framework Agency Charge Rate within your Trust for Sonographers
8. The highest Off Framework Agency Charge Rate within your Trust for Sonographers.
9. A list of any agency (Framework and Off Framework) that have ongoing block booking arrangements for Sonographers within your Trust within the identified time frame (01.06.2025 – 01.01.2026)

Compounding and Automated Compounding Devices

Estates, GHNHSFT - Redirect, Pharmacy

, I would like to request information on compounding practice, and automated compounding devices in your aseptic unit. If you are in the process of opening an aseptic unit, please answer these questions as if it was open, based on estimated volumes.

Section 1
Do you compound bespoke parenteral nutrition in your aseptic unit? (This should not include adding vitamins and trace elements to multi chamber licensed products)
• Yes
• No
If no, why?
• Completely Outsourced
• Patient Numbers
• Other, please specify

If no, please proceed to Section 2 and 3.
If yes, please proceed with the questions below.

How do you compound bespoke parenteral nutrition?
• Automated Compounding Device (ACDs)
• Manual, Gravity or Syringe Fill (Please proceed to Section 2 and 3)
• Other, please specify (Please proceed to Section 2 and 3)

If you compound bespoke parenteral nutrition with an ACD, please answer the below.

How many validated and in-use ACDs do you have in your aseptic unit?

How many spares/not in-use ACDs do you have?

Do you own your ACDs or are they loaned?

How old are your ACDs?
• Between 1 and 3 years old
• Between 4 and 8 years old
• Older than 8 years old

Section 2
Do you compound Systemic Anti-cancer Therapies (SACT) (chemotherapy and/or immunotherapy) in your aseptic unit?
• Yes
• No
If no, why?
• Completely Outsourced
• Patient Numbers
• Other, please specify

If no, please proceed to Section 3.
If yes, please proceed with the questions below.

How do you compound chemotherapy?
• Manually
• Automated compounding devices (ACDs)
• Repeater pumps
• Other, please specify

If you use automation, how many ACDs do you have validated and in use?

What drug categories do you compound, and in what quantity?
• MABS
• Cytotoxics
• Other, please specify

What are your final filling containers?
• IV bags
• Syringes
• Elastomeric devices
• Other, please specify

Section 3
Do you compound antibiotic preparations in your aseptic unit?
• Yes
• No
If no, why?
• Outsourced
• Patient Numbers
• Other, please specify

If no, please disregard this section.
If yes, please proceed with the questions below.

How do you compound antibiotics?
• Manually
• Automated compounding devices (ACDs)
• Repeater pumps
• Other, please specify

If you use automation, how many ACDs do you have validated and in use?

What antibiotic quantities do you manufacture?

What are your final filling containers?
• IV bags
• Syringes
• Elastomeric devices
• Other, please specify

FDP Rollout

IT, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust, This is a request for information under the Freedom of Information Act
2000 regarding the local rolllout and implementation of the Federated Data Platform (FDP), provided by Palantir Technologies.

Please can you provide me with the following information:

1) Is the Trust already using the FDP? If the Trust isn’t already using the FDP can you please provide me with a specific rollout date?

2) It has been widely reported that there have been hidden and unbudgeted for costs to implementing the FDP at local and national levels. What is the projected and locally budgeted for cost of the rollout and implementation of the FDP that hasn’t already been provided for by NHSE national funding from the initial FDP contract? This might include, but is not limited to, extra training costs, staff costs, consultancy workers, hardware, software, licenses, or other IT related costs.

4) What new jobs or roles have been created within the Trust to enable the implementation, development and running of the FDP? What other internally allocated resources in relation to the rollout and implementation of the FDP are there?

3) What FDP instances/apps/products are currently in use and what are planning to be rollout out?

I would like to receive the information in a PDF format.

Yours faithfully,

Viscosupplementation Injections

Pharmacy

Under the Freedom of Information Act, please could you answer the following questions:

1. Does your organisation use/perform Viscosupplementation injections?

2. If so, how much did your organisation spend on Viscosupplementation between the period of 01/01/2025 to 31/12/2025?

3. If your organisation used Viscosupplementation between the period 01/01/2025 to 31/12/2025, which brand(s) Viscosupplement did you use?

4. How many units of each brand of Viscosupplement did you use?

Adult Acute Mental Health Inpatient Beds

Health, MH Services

Dear Freedom of Information Team,

I am writing to request information under the Freedom of Information Act 2000.

Please provide the information requested below in relation to adult acute mental health inpatient beds within your Trust.

For the purposes of this request:

• “Adult” refers to patients aged 18 and over.
• “Adult acute bed” refers to general adult acute mental health inpatient wards and excludes specialist services (e.g. PICU, forensic, CAMHS, learning disability, older adults, rehabilitation, or long-stay wards), unless these are routinely classified by your Trust as adult acute.
• The reporting period is the last 18 months from the date of this request, unless otherwise stated. Information requested

1. Length of stay over 12 months In the last 18 months, how many adult patients detained under the Mental Health Act have had a length of stay exceeding 12 months in an adult acute bed within the Trust? (Please note: the date of admission may fall outside the 18-month reporting period.)

2. Multiple admissions In the last 18 months, how many adult patients have had three or more admissions (i.e. re-admitted two times or more) to an adult acute bed within the Trust?

3. Average length of stay In the last 18 months, what is the average length of stay for adult patients admitted to adult acute wards within the Trust? If possible,

I would appreciate the data provided in aggregate form (e.g. total numbers and averages), and I am happy to receive the response in Excel, CSV, or another standard electronic format.

If any part of this request is exempt under the Act, please provide the reason for the exemption and release any non-exempt information where possible.

Should clarification be required to process this request, please contact me as soon as possible.

I understand that under the Freedom of Information Act 2000, a response should be provided within 20 working days.

Thank you for your time and assistance.

Kind regards

Haemophilia A and B and Von Willebrand Patients

GHNHSFT - Redirect, Health, Pharmacy

Hi FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information (FOI) Act 2000 I would like to obtain the following information:

In the last 3 months (October, November, December 2025), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Brand name Number of treated patients Volume used (IUs, mg)
Hemlibra (non-inhibitor patients)
Hemgenix
Altuvoct
Advate
Adynovi
Elocta
Esperoct
NovoEight
ReFacto AF
Nuwiq
Hympavzi
Idelvion
Refixia
Alprolix
BeneFIX
Replenine
Rixubis
Veyvondi
Voncento
Wilate
Willfact

Best wishes,

Agency Spend – General and Specialist Nurses

ESR/Workforce, Finance, Nursing & Agency Nursing

To whom it may concern,

For the 6-month period ending 1st January 2026, can you please provide:

1. Total Framework Agency Spend for both general and specialist nurses.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

2. Total Off Framework Agency Spend for both general and specialist nurses.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

3. Total hours filled by Framework Agencies for both general and specialist nurses and a breakdown of hours for each specialty.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

4. Total hours filled by Off Framework Agencies for both general and specialist nurses and a breakdown of hours for each specialty.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

5. A list of all Framework Agencies utilised by the Trust for both general and specialist nurses.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

6. A list of all Off Framework Agencies utilised by the Trust for both general and specialist nurses and total number of shifts for each Off Framework agency:
*Specialist Nurses: Any Nursing Role that is not a general nurse.

7. The highest Framework Agency Charge Rate within your Trust for both general and specialist nurses.
*Specialist Nurses: Any Nursing Role that is not a general nurse.

8. The highest Off Framework Agency Charge Rate within your Trust for both general and specialist nurses.
*Specialist Nurses: Any Nursing Role that is not a general nurse

9. A list of any agency (Framework and Off Framework) that have ongoing block booking arrangements for both general and specialist within your Trust within the identified time frame (01.06.2025 – 01.01.2026):
*Specialist Nurses: Any Nursing Role that is not a general nurse

Yours Sincerely,

Translation and Interpretation Costs by Language in 2024

Communications, Finance, Organisation

Dear Gloucestershire Health and Care NHS Foundation Trust,

I wish to make a freedom of information request and would be grateful if you could supply the following information within twenty working days:

From January 2024 to December 2024, the total expenditure on translation and interpretation services, broken down by language these services were provided in (specifying the target language for each).

Best wishes,

Locum / AHP / HSS Spend

ESR/Workforce, Finance, Locum Doctors, Nursing & Agency Nursing

Good Morning,

Please can you provide the below information:

From 1st October 2025 to 31st December please provide a breakdown of:
• Total trust spend with framework agencies for locum AHP/HSS staffing.

Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per band
• Spend per specialty
• Spend per agency name

In the period 1st October 2025 to 31st December please provide a breakdown of:
• Total trust spend with off-framework agencies for locum AHP/HSS staffing.

Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per band
• Spend per specialty
• Spend per agency name

In the period 1st October 2025 to 31st December please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum AHP/HSS staffing

Please provide a further breakdown for locum AHP/HSS staffing by:
• Spend per grade
• Spend per specialty
• Spend per internal or associated external provider

Please confirm your allocated budget for agency locum AHP/HSS staffing for the period 1st October 2025 to 31st December

Please confirm the framework you utilise for AHP/HSS agency staff.

Appreciate your help with this request in advance.

Kind regards,

MPAC Trainees

Staff Training, Staffing

I would like to please make a freedom of information request dated 20/01/2026 regarding the following:

1. Do you have any current MPAC trainees?
a. If yes, how many MPAC trainees do you have?

2. Are you employing any Multi-Professional Approved Clinicians (MPACs)?
a. If yes, how many Multi-Professional Approved Clinicians (MPACs) are you employing?

3. Do your employed MPACs take on Responsible Clinician (RC) roles?
a. If yes, in what setting do they take on these roles? For example, are they acting as RC on an individual level for individual service users, or at a team level for a ward?

4. Do your employed MPACs have any clear supervisory roles for resident doctors?

5. Do your employed MPACs take on the nominated deputy role for completing 5(2)?

6. Do your employed MPACs take part on the on call rota?

7. Do you have a clear policy to determine allocation of psychiatrists or MPACs as the RC?

8. In cases where the MPAC is acting as the RC but not a qualified prescriber, what mechanism do you have in place to ensure a suitably qualified AC is in charge of prescriptions?

Ultrasound Systems / Equipment

Estates, Medical Equipment

Dear FOI Team,
Gloucestershire Health and Care NHS Foundation Trust
Request for Information under the Freedom of Information Act
I would be most grateful if you would provide me, under the Freedom of Information Act, details with respect to the Trust below, details of which can be found below:

1. How many Ultrasound Systems does the Trust own?
2. Please provide the Original Equipment Manufacturer name of each installed Ultrasound System.
3. Please provide the Original Equipment Manufacturer System Type of each installed Ultrasound System.
4. Please list the Departmental location of each individual Ultrasound System asset installed across the Trust.
5. Does the Trust maintain any of the Trust’s Ultrasound Systems by utilising external service provider(s)?
6. Does the Trust maintain any of the Trust’s Ultrasound Systems by utilising your own internal Engineering staff?
7. If an external service provider(s) is used, please provide the name of the contracted service provider?
8. If an external service provider(s) is used, what was the contract award value?
9. If an external service provider(s) is used, what is the contract type – PPM/ Fully- Comprehensive / Ad-hoc support?
10. If an external service provider(s) is used, what is the contract renewal date(s)?
11. Please provide the name, email address of the role responsible for managing medical devices within the Trust
12. If medical device maintenance is managed internally, how many clinical engineers are employed by the Trust?
13. What is the current % of assets ‘within service date’ – i.e., the date by which a device must be serviced has not expired?

Definitions

Ultrasound Devices
For the purposes of this request, this includes any diagnostic Ultrasound equipment, such as portable ultrasound units, point-of-care ultrasound (PoCUS) devices, or cart-based ultrasound systems.

PPM
Planned Preventative Maintenance, i.e. annual service.

Fully Comprehensive
Maintenance contract covering the cost of Planned Maintenance and cost of repair parts and labour of equipment.

Ad-hoc support
Subcontracted work to an engineering company on an informal basis.

*For clarity, contact details are kept in the strictest confidence. These details are used only to contact regarding information of legitimate interest for the relevant contracts.

Your sincerely,

Locum Nursing Spend

Nursing & Agency Nursing

Good morning,

Please can you provide the below information:

In the period 1st October 2025 to 31st December 2025 please provide a breakdown of:
• Total trust spend with framework agencies for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name

In the period 1st October 2025 to 31st December 2025 please provide a breakdown of:
• Total trust spend with off framework agencies for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name

In the period 1st October 2025 to 31st December 2025 please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum nurses
Please provide a further breakdown for locum nurses by:
• Spend per band
• Spend per specialty
• Spend per agency name

Please confirm the total number of nursing shifts booked during this period for all agency nursing only, no bank staff nursing to be included (1st October 2025 to 31st December 2025)

Please confirm the total number of nursing shifts booked above NHSE capped rates during this period for all agency nursing only, no bank staff nursing to be included (1st October 2025 to 31st December 2025)

Please confirm the framework you utilise for nursing agency staff.

Bank Staff Activity

ESR/Workforce

Dear FOI Team, i have attached the request uploaded below thank you

Data Subject Access Request (DSAR) – Not and FOI

Not an FOI

All medical records from Brownhills Cheltenham, CAMHS Cheltenham (Gloucestershire), Evergreen Psychiatrists Camhs Cheltenham

Fire Alarm Systems / Waking Watch

Estates, Safety and Security

For each hospital site operated by your trust, please provide the following information.

If information is not held at hospital level, please provide it at the closest available level of aggregation.

1. Does the hospital have a fully compliant fire alarm system in operation covering the entirety of this hospital’s estate? Please answer Yes/No.

2. During the 2024/25 financial year, did the hospital employ or contract a ‘waking watch’ service at any point? Please answer Yes/No.

a. If Yes, how much did the hospital spend on waking watch services during the 2024/25 financial year?

b. If Yes, what were the primary reasons for having a waking watch service?

Please select all which apply:

(i.) Fire alarm system absent, incomplete or not fully operational
(ii.) External wall system or cladding-related fire safety concerns
(iii.) Other

Injuries Treated in A&E – Collision with an E-Bike / Cyclist

Clinical Activity Data, GHNHSFT - Redirect

I am writing to make an application for data using the Freedom of Information Act. Please could you release the below in a “machine readable” format.

If available, please provide for me statistics for either the calendar or financial years from 2020 to 2025 (or 2020/1 to 2025/6, or as much as available for the latter).

Across the entire Trust, how many people have been treated for injuries in A&E where they have been recorded as having been involved in a collision with an e-bike (of any kind)?

If at all possible, can you say whether they were pedestrians or fellow cyclists? I am particularly interested in the former.

Please include the patient’s age, sex and whether they have any recorded disability.

Can you please break the above down for each hospital within your Trust, including if possible the date of admission and discharge.

Please include the severity of the injury (ie lower/upper limb fracture/concussion).

If available, please include how many – if any – of these culminated in a fatality.

If available, please include what type of e-bike was involved. I understand some notes have stated whether a “Lime”, “Forest”, “Human Forest” or “Tier” were involved.

If possible, please state whether the bike was moving or stationary.

On some occasions, vulnerable pedestrians, such as the blind or elderly, have tripped over badly parked e-bikes. To be able to identify such incidents would be very useful.

If there are any other details that you could include, such as a short description of any notes (without obviously revealing the injured parties identities) I would be very grateful.

I totally understand that some information may be readily available, while other elements may prove more difficult. Essentially,

I’m trying to establish how common (or not) it is for pedestrians to be injured by e-bikes. So, mere numbers will be a big help. However, the more detail you can share will help me build a more accurate picture.

I believe you have 20 working days in which to reply.

I look forward to hearing from you. If there is anything I can do to assist, please do not hesitate to contact me via email or on the number below.

Yours

Critical Incidents Declaration Records (Nov 2023 – Nov 2025)

Safety and Security, Serious Incidents

Dear Sir/Madam,

This is a freedom of information request regarding critical incidents declared by hospitals within your NHS Trust between 13th November 2023 and 13th November 2025.

Request Details: I am seeking information about the number of critical incidents declared by all hospitals within your NHS trust during two specific one-year periods:

– Period 1: 13th November 2023 – 12th November 2024
– Period 2: 13th November 2024 – 12th November 2025

Please provide this information in a table format as follows:

Hospital Name Number of incidents between 13.11.2023 – 12.11.2024 Number of incidents between 13.11.2024 – 12.11.2025
[Hospital 1]
[Hospital 2]

Clarification:
– By “critical incident,” I am referring to incidents declared under your Trust’s major incident/critical incident procedures, typically involving significant disruption to normal services.
– Please include all hospital sites/locations within your Trust
– If no critical incidents were declared during either period for any hospital, please indicate “0”.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in section 12 of the Freedom of Information Act, please provide advice and assistance, under the section 16 obligations of the act, as to how I can refine my request.

If you have any queries please do not hesitate to contact me for clarification via this email.

Thank you for your assistance,

Kind regards,

Ambient AI Systems for Clinical Documentation & Transcription

Dear Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information Act 2000, I would like to request information regarding your use of ambient or AI-assisted systems to support clinical documentation during patient consultations.

For the purposes of this request, “ambient AI” refers to systems that passively listen to, record, transcribe, summarise, or otherwise process clinician–patient conversations in order to generate clinical notes, letters, or structured records, either in real time or after the consultation.

Please confirm:

Whether the Trust currently uses, is piloting, or has contracted for any ambient AI or AI-assisted clinical documentation system (for example systems provided by suppliers such as Heidi, Lexacom, Tortoise, or similar).

If yes, for each system in use or under contract, please provide:

– The name of the software/system and the supplier.
– The clinical setting(s) in which it is used (for example outpatient clinics, community services, mental health services).
– Whether the system records live audio, processes audio locally, or transmits audio to a third party or cloud service.
– The total contract value or annual spend.
– The contract start date and end date, including any extension options.

Whether the system was procured via a formal procurement framework, and if so the name of the framework used (for example NHS SBS, Crown Commercial Service, Health Systems Support Framework, or similar).

The department and job title responsible for oversight of the system (for example Medical Director, Chief Clinical Information Officer, or equivalent).

If the Trust does not currently use an ambient AI system, please confirm whether procurement, evaluation, or pilot activity has taken place within the last 24 months.

If any part of this request is unclear, please contact me for clarification.

Yours faithfully,

Patient Transfers and Beds

MH Services

Good Afternoon,
I am writing to request information under the Freedom of Information (FOI) Act 2000.
My questions are as follows:
1) How much was spent on secure mental health patient transfers by private ambulances in the 6 months to 30th November 2025
2) How many journeys were made on secure mental health patient transfers by private ambulances in the 6 months to 30th November 2025
3) Please provide a list of all private ambulance companies used for secure mental health patient transfers in the 6 months to 30th November 2025 and for each detail:
(a) Number of jobs
(b) Cost of providing the service

4) How much was spent on mental health patient bed watch by private companies in the 6 months to 30th November 2025
5) How many mental health patients were looked after by private bed watch companies in the 6 months to 30th November 2025
6) Please provide a list of all companies that provided mental health patient bed watch services in the 6 months to 30th November 2025 and for each detail:
(a) Number of patients looked after
(b) Cost of providing the service

7) What is the selection criteria for deciding which companies to use for secure mental health patient transfer by private ambulances
8) What is the selection criteria for deciding which companies to use for mental health patient bed watch by private companies

Thank you in advance for providing this information.

Regards,

Call-Off Contracts – Framework Agreements

Contracts

Hello,

I would like to make a freedom of information request.

I am doing a research project investigating call-off contracts in the public sector. I have identified three potential call-off contracts awarded by Gloucestershire Health and Care NHS Foundation Trust, but I can’t find details of the framework agreements they were awarded from, or which lots were used.

I have attached an Excel file that contains the information I am looking at. The last two columns (“Title of framework used” and “Further framework info”) is where I am missing information. Please could you provide the name of the specific framework agreement or DPS/Dynamic Market used here, as well as the lot used if the framework was divided into lots. If there is any further info which you think would help me locate the framework agreements (e.g., a link to the framework’s Contract Finder or FTS listing, the framework provider, or a widely-used reference number such as CCS’s RM codes), please use the final column for this. Please use the second column for the relevant lot information.

Please note that I have identified these contracts as possible call-off contracts, so some of them might not be. Some could be, for instance, procured directly (without being called off from a framework agreement), or could be themselves notices of the establishment of a framework agreement. Therefore I would kindly ask you to specify in these incidences what kind of procurement was used in the “Title of framework used” column.

I have provided the title, description, the publication date, and procedure type used to award each potential call-off, as well as a URL link to the call-off in question and a unique reference ID for each potential call-off. Please let me know if there is anything else you need to complete the request.

Thank you very much in advance.

Best wishes,

« Older Entries

Next Entries »

Responses

Get in touch with us

Better Care Together